2016
DOI: 10.1055/s-0042-108186
|View full text |Cite
|
Sign up to set email alerts
|

Reversible Anti-Spermatogenic Effect of Piperine on Epididymis and Seminal Vesicles of Albino Rats

Abstract: From the results of this study, we can conclude that piperine has the potential to become a good lead for the reversible male oral contraceptive research.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(20 citation statements)
references
References 32 publications
0
20
0
Order By: Relevance
“…Research findings also revealed that piperine could improve fertility through its positive effects on sperm count, viability and motility, weight of epididymis, caput, cauda, corpus, and seminal vesicles. However, some negative impacts, such as lowering of seminal fructose and an increase in malondialdehyde contents have also been observed by Chinta and Periyasamy (2016). Furthermore, piperine at a dose of 100 mg/kg decreased epididymis caput, cauda, and corpus weights (D'cruz & Mathur, 2005; Daware et al, 2000).…”
Section: Health Perspectivesmentioning
confidence: 81%
“…Research findings also revealed that piperine could improve fertility through its positive effects on sperm count, viability and motility, weight of epididymis, caput, cauda, corpus, and seminal vesicles. However, some negative impacts, such as lowering of seminal fructose and an increase in malondialdehyde contents have also been observed by Chinta and Periyasamy (2016). Furthermore, piperine at a dose of 100 mg/kg decreased epididymis caput, cauda, and corpus weights (D'cruz & Mathur, 2005; Daware et al, 2000).…”
Section: Health Perspectivesmentioning
confidence: 81%
“…In our previous study, we have demonstrated the reversible spermatotoxic effect of piperine on male albino rats. [ 65 ] Piperine significantly impaired the testicular function of rats in the group ED and E4D through elevating the testicular cholesterol levels, resulting in the inhibition of the steroidogenesis after the treatment period. [ 66 ] A slight increase in the testicular cholesterol level was observed in the group E7D.…”
Section: Resultsmentioning
confidence: 99%
“…In young adult male rats that orally received 10 mg piperine/kg bw/day (suspended in normal saline containing 0.5% carboxymethyl cellulose) for 60 days, Chinta and co-workers observed a statistically significantly ( p < 0.05) reduced epididymal sperm count, sperm motility and sperm viability compared to the control group (the latter receiving the vehicle only), accompanied by histopathological changes in the testes and epididymides; statistically significantly increased serum gonadotropins (FSH, LH), with a reduced intra-testicular testosterone concentration; and statistically significantly reduced activity of anti-oxidant enzymes or other enzymes in the testes and epididymides (for details, see Table 1 ) [ 16 , 62 ]. Data on reproductive organ weights were also recorded in this study, but in one of the two publications dealing with this study, inconsistencies were noticed between the testes weights and calculated indexes or a coefficient based on testes and body weights [ 62 ].…”
Section: Safety Aspectsmentioning
confidence: 99%
“…Primarily in in vitro and in animal studies, as well as in some human studies, piperine has been shown to be a biologically versatile compound that can interact with a variety of chemically and functionally diverse biomolecular targets, such as enzymes, membrane transporters, receptors or other biomolecules. For example, piperine may provide protection against forms of oxidative damage and improve the activities of compromised anti-oxidative defence mechanisms (e.g., related to superoxide dismutase or catalase), but depending on the study settings, may also decrease the anti-oxidative defence mechanisms and among others, piperine further displays the potential to influence the activity of drug-metabolizing enzymes, including enzymes involved in phase I (cytochrome P-450-enzymes) and phase II metabolism (e.g., UDP-glucuronosyltransferases), to interact with cellular drug transporters (e.g., P-glycoprotein) or to modulate the cellular targets (monoamine oxidase) associated with neurodegenerative diseases [ 1 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%